These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37578019)

  • 1. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
    Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
    Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
    Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
    Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in
    Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M
    Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
    Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
    J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHCHD2 mutant mice display mitochondrial protein accumulation and disrupted energy metabolism.
    Liao SC; Kano K; Phanse S; Nguyen M; Margolis E; Fu Y; Meng J; Moutaoufik MT; Chatterton Z; Aoki H; Simms J; Hsieh I; Suteja F; Sei Y; Huang EJ; McAvoy K; Manfredi G; Halliday G; Babu M; Nakamura K
    bioRxiv; 2024 Aug; ():. PubMed ID: 39257750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson's disease.
    Liu X; Wang Q; Yang Y; Stewart T; Shi M; Soltys D; Liu G; Thorland E; Cilento EM; Hou Y; Liu Z; Feng T; Zhang J
    Acta Neuropathol Commun; 2021 Mar; 9(1):37. PubMed ID: 33685516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
    Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
    Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of CHCHD2 may Contribute to Parkinson's Disease by Reducing Expression of NFE2L2 and RQCD1.
    Li K; Ning P; Liu B; Yang H; Zhu Y; Yin W; Zhou C; Ren H; Yang X
    Curr Neurovasc Res; 2022; 19(1):19-29. PubMed ID: 35388756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.
    Fan TS; Lin HI; Lin CH; Wu RM
    Neurobiol Aging; 2016 Feb; 38():218.e1-218.e2. PubMed ID: 26725463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
    Shammas MK; Huang TH; Narendra DP
    Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHCHD2 mutational screening in Brazilian patients with familial Parkinson's disease.
    Voigt DD; Nascimento CM; de Souza RB; Cabello Acero PH; Campos Júnior M; da Silva CP; Pereira JS; Rosso AL; Araujo Leite MA; Vasconcellos LFR; Della Coletta MV; da Silva DJ; Nicaretta DH; Gonçalves AP; Dos Santos JM; Calassara V; Santos-Rebouças CB; Pimentel MMG
    Neurobiol Aging; 2019 Feb; 74():236.e7-236.e8. PubMed ID: 30342766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
    Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
    Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
    Li NN; Wang L; Tan EK; Cheng L; Sun XY; Lu ZJ; Li JY; Zhang JH; Peng R
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1148-1152. PubMed ID: 27626775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostatic p62 levels and inclusion body formation in CHCHD2 knockout mice.
    Sato S; Noda S; Torii S; Amo T; Ikeda A; Funayama M; Yamaguchi J; Fukuda T; Kondo H; Tada N; Arakawa S; Watanabe M; Uchiyama Y; Shimizu S; Hattori N
    Hum Mol Genet; 2021 Apr; 30(6):443-453. PubMed ID: 33631794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.